European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors : practical guidance for use in patients at very high cardiovascular risk

Landmesser, UlfChapman, M. JohnFarnier, MichelGencer, BarisGielen, StephanHovingh, G. KeesLüscher, Thomas F.Sinning, DavidTokgözoğlu, LaleWiklund, OlovZamorano, Jose LuisPinto, Fausto J.Catapano, Alberico L.2018-07-182018-07-182016European Heart Journal, Volume 38, Issue 29, 1 August 2017, Pages 2245–22550195-668Xhttp://hdl.handle.net/10451/34224Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2016.engEuropean Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors : practical guidance for use in patients at very high cardiovascular riskjournal article10.1093/eurheartj/ehw480